A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study ...

The symptoms of pancreatic cancer can be nonspecific, which means identifying the disease is often a challenge.

A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...

Q: I just learned I have prediabetes. I also learned that a lot of people with pancreatic cancer have trouble with blood ...

In trials, a vaccine for pancreatic cancer developed by Sloan-Ketterin and BioNTech showed promise, but researchers say it is ...

Scientists have developed a new mRNA vaccine to treat pancreatic cancer that may extend patients' lifespans by 8 to 10 years.

There is new hope in the fight against pancreatic cancer after early trials showed that personalized mRNA vaccines can target ...

A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.

Pancreatic cancer is fueled by connections to the nervous system. This is reported by scientists from the German Cancer ...